Skip to content
StockMarketAgent
Direct answer
KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $736, high $1244, with mid-point at $984.
Stock analysis

KLAC KLA Corporation fair value $984–$1,244

KLAC
By StockMarketAgent.AI team· supervised by
Analizzato: 2026-05-08Prossimo aggiornamento: 2026-08-08Methodology v2.4Archetype: Mature compounderNASDAQ · Information Technology
View archive
Prezzo
$1869.19
▼ -884.78 (-47.33%)
Valore equo
$984
$984–$1244
Valutazione
Vendere
confidence 84/100
Potenziale rialzo
-47.3%
upside to fair value
Margine di Sicurezza
$836.75
buy below · 15%
Capitalizzazione
$244.2B
P/E fwd 37.7
Fallback in ingleseIT
Mostrando la fonte in inglese mentre traduciamo
Questo report non è ancora stato tradotto. Aggiorna tra qualche minuto una volta che la coda di traduzione avrà recuperato.

§1 Sintesi

  • Composite fair value $984 with high case $1,244.
  • Implied downside of 47.3% to fair value.
  • Moat 9/10 · confidence 84/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$984
Margin of safety
-89.9%
Confidence
84/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$1,869.19Price
FV $984.41
High $1,243.87

KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Dominant market share in advanced
    Dominant market share in advanced metrology and inspection.
  • High capital intensity of advanced
    High capital intensity of advanced node defect detection.
  • Bull thesis
    Value: Extreme overvaluation relative to normalized cash flows.

§2 Scenario ribassista

A synchronized downturn in global WFE spending combined with strict export bans on advanced metrology tools to China severely contracts near-term revenue. Elevated R&D requirements for 2nm transitions crush operating leverageLeverageThe proportion of debt in the company's capital structure. Commonly measured as Debt/EBITDA, Debt/Equity, or Net Debt/EBITDA., forcing margins well below mid-cycle averages.

Come questa tesi può fallire

China Export Ban Expansion

· Medium

Complete restriction on all tier-1 process control equipment sales to Chinese foundries, eliminating a high-margin revenue vector.

FV impact
High
Trigger
12-24 months

WFE Cyclical Collapse

· Medium

Prolonged memory and foundry capex freeze delays 2nm and advanced packaging ramps, stalling KLA's growth trajectory.

FV impact
High
Trigger
6-18 months

Margin Compression via R&D

· Low

Defect detection at angstrom levels demands exponentially higher R&D, structurally degrading peak operating margins below 35%.

FV impact
Moderate
Trigger
24-36 months
Segnali di allerta precoce da monitorare
MetricaAttualeSoglia di attivazione
Consecutive quarters of declining WFE capex forecasts.MonitorDeterioration versus the report thesis
Increased stringency in US Department of Commerce export controls.MonitorDeterioration versus the report thesis
Sequential operating margin degradation below 38%.MonitorDeterioration versus the report thesis
Delay in major foundry 2nm production schedules.MonitorDeterioration versus the report thesis
Deceleration in advanced packaging (CoWoS) capacity expansion.MonitorDeterioration versus the report thesis

§3 Storia finanziaria

Conto economico — ultimi sei periodi
VoceT−0T−1T−2T−3T−4CAGR
Periodo2021-06-302022-06-302023-06-302024-06-302025-06-30Trend
Ricavi$9.21B$10.50B$9.81B$12.16B+7.2%
Utile lordo$5.62B$6.28B$5.88B$7.40B+7.1%
Reddito operativo$3.65B$3.99B$3.64B$5.01B+8.2%
Utile netto$3.32B$3.39B$2.76B$4.06B+5.2%
EPS (diluito)$13.37$21.92$24.15$20.28+11.0%
EBITDA$4.01B$4.50B$3.90B$5.34B+7.4%
R&S$1.11B$1.30B$1.28B$1.36B+5.3%
SG&A$860.0M$986.3M$969.5M$1.03B+4.6%

Punteggi di qualità

Piotroski F-score
9 / 9
Composito qualità 0–9
Altman Z-score
14.61
Rischio di fallimento (>3 sicuro)
Beneish M-score
-2.25
Rischio di manipolazione degli utili
OCF / Utile netto
1.01×
>1 indica alta qualità degli utili
Soglia di qualità contabile
Pass
Soglia corretta per settore
ROIC
36.2%
Rendimento del capitale investito
Sezione 3

Numbers analysis

Allocazione del capitale

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Abbonati individuali — da §4 in poi11 sezioni in più

Leggi l'analisi completa — 11 sezioni in più.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Report completo per ogni ticker coperto
24 mesi di archivio rating
Briefing della watchlist + avvisi di variazione del rating
Esportazione PDF + DOCX in qualsiasi lingua
Inizia la prova gratuita
Annulla in qualsiasi momento.
FAQ

KLAC — frequently asked questions

  1. Based on our latest analysis, KLAC looks meaningfully overvalued. The current price is $1869 versus a composite fair-value midpoint of $984 (range $736–$1244), which implies roughly 47.3% downside to the midpoint.
Related coverage

Names readers of KLAC also follow

Same archetype: mature-compounder
Same sector: Information Technology